![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
Part 1
Part 2
Part 3
Part 5
Wearable Injectors and Connected Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wearable Injectors and Connected Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Wearable Injectors and Connected Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Wearable Injectors and Connected Devices key manufacturers include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation and West Pharma, etc. Gerresheimer, Owen Mumford, Sonceboz are top 3 players and held % sales share in total in 2022. Wearable Injectors and Connected Devices can be divided into Disposable and Reusable, etc. Disposable is the mainstream product in the market, accounting for % sales share globally in 2022. Wearable Injectors and Connected Devices is widely used in various fields, such as Hospitals, Clinics, Home Care Settings and Others, etc. Hospitals provides greatest supports to the Wearable Injectors and Connected Devices industry development. In 2022, global % sales of Wearable Injectors and Connected Devices went into Hospitals filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Wearable Injectors and Connected Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Gerresheimer Owen Mumford Sonceboz United Therapeutics Ypsomed Elcam Medical Enable Injections Unilife Corporation West Pharma Eitan Medical BD Medical Noble International Insulet Amgen Roche CeQur ScPharmaceuticals Segment by Type Disposable Reusable Segment by Application Hospitals Clinics Home Care Settings Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the Wearable Injectors and Connected Devices market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Wearable Injectors and Connected Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Wearable Injectors and Connected Devices industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Wearable Injectors and Connected Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Wearable Injectors and Connected Devices introduction, etc. Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Wearable Injectors and Connected Devices market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
1 Wearable Injectors and Connected Devices Market Overview
1.1 Wearable Injectors and Connected Devices Product Overview
1.2 Wearable Injectors and Connected Devices Market Segment by Type
1.2.1 Disposable
1.2.2 Reusable
1.3 Global Wearable Injectors and Connected Devices Market Size by Type
1.3.1 Global Wearable Injectors and Connected Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Wearable Injectors and Connected Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Wearable Injectors and Connected Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Wearable Injectors and Connected Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Wearable Injectors and Connected Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Wearable Injectors and Connected Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Wearable Injectors and Connected Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Wearable Injectors and Connected Devices Sales Breakdown by Type (2018-2023)2 Global Wearable Injectors and Connected Devices Market Competition by Company
2.1 Global Top Players by Wearable Injectors and Connected Devices Sales (2018-2023)
2.2 Global Top Players by Wearable Injectors and Connected Devices Revenue (2018-2023)
2.3 Global Top Players by Wearable Injectors and Connected Devices Price (2018-2023)
2.4 Global Top Manufacturers Wearable Injectors and Connected Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Wearable Injectors and Connected Devices Market Competitive Situation and Trends
2.5.1 Wearable Injectors and Connected Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Wearable Injectors and Connected Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wearable Injectors and Connected Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Wearable Injectors and Connected Devices Market
2.8 Key Manufacturers Wearable Injectors and Connected Devices Product Offered
2.9 Mergers & Acquisitions, Expansion3 Wearable Injectors and Connected Devices Status and Outlook by Region
3.1 Global Wearable Injectors and Connected Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Wearable Injectors and Connected Devices Historic Market Size by Region
3.2.1 Global Wearable Injectors and Connected Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Wearable Injectors and Connected Devices Sales in Value by Region (2018-2023)
3.2.3 Global Wearable Injectors and Connected Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Wearable Injectors and Connected Devices Forecasted Market Size by Region
3.3.1 Global Wearable Injectors and Connected Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Wearable Injectors and Connected Devices Sales in Value by Region (2024-2029)
3.3.3 Global Wearable Injectors and Connected Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)4 Global Wearable Injectors and Connected Devices by Application
4.1 Wearable Injectors and Connected Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home Care Settings
4.1.4 Others
4.2 Global Wearable Injectors and Connected Devices Market Size by Application
4.2.1 Global Wearable Injectors and Connected Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Wearable Injectors and Connected Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Wearable Injectors and Connected Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Wearable Injectors and Connected Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Wearable Injectors and Connected Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Wearable Injectors and Connected Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Wearable Injectors and Connected Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Wearable Injectors and Connected Devices Sales Breakdown by Application (2018-2023)5 North America Wearable Injectors and Connected Devices by Country
5.1 North America Wearable Injectors and Connected Devices Historic Market Size by Country
5.1.1 North America Wearable Injectors and Connected Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Wearable Injectors and Connected Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Wearable Injectors and Connected Devices Sales in Value by Country (2018-2023)
5.2 North America Wearable Injectors and Connected Devices Forecasted Market Size by Country
5.2.1 North America Wearable Injectors and Connected Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Wearable Injectors and Connected Devices Sales in Value by Country (2024-2029)6 Europe Wearable Injectors and Connected Devices by Country
6.1 Europe Wearable Injectors and Connected Devices Historic Market Size by Country
6.1.1 Europe Wearable Injectors and Connected Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Wearable Injectors and Connected Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Wearable Injectors and Connected Devices Sales in Value by Country (2018-2023)
6.2 Europe Wearable Injectors and Connected Devices Forecasted Market Size by Country
6.2.1 Europe Wearable Injectors and Connected Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Wearable Injectors and Connected Devices Sales in Value by Country (2024-2029)7 Asia-Pacific Wearable Injectors and Connected Devices by Region
7.1 Asia-Pacific Wearable Injectors and Connected Devices Historic Market Size by Region
7.1.1 Asia-Pacific Wearable Injectors and Connected Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Wearable Injectors and Connected Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Wearable Injectors and Connected Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Wearable Injectors and Connected Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Wearable Injectors and Connected Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Wearable Injectors and Connected Devices Sales in Value by Region (2024-2029)8 Latin America Wearable Injectors and Connected Devices by Country
8.1 Latin America Wearable Injectors and Connected Devices Historic Market Size by Country
8.1.1 Latin America Wearable Injectors and Connected Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Wearable Injectors and Connected Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Wearable Injectors and Connected Devices Sales in Value by Country (2018-2023)
8.2 Latin America Wearable Injectors and Connected Devices Forecasted Market Size by Country
8.2.1 Latin America Wearable Injectors and Connected Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Wearable Injectors and Connected Devices Sales in Value by Country (2024-2029)9 Middle East and Africa Wearable Injectors and Connected Devices by Country
9.1 Middle East and Africa Wearable Injectors and Connected Devices Historic Market Size by Country
9.1.1 Middle East and Africa Wearable Injectors and Connected Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Wearable Injectors and Connected Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Wearable Injectors and Connected Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Wearable Injectors and Connected Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Wearable Injectors and Connected Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Wearable Injectors and Connected Devices Sales in Value by Country (2024-2029)10 Company Profiles
10.1 Gerresheimer
10.1.1 Gerresheimer Company Information
10.1.2 Gerresheimer Introduction and Business Overview
10.1.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gerresheimer Wearable Injectors and Connected Devices Products Offered
10.1.5 Gerresheimer Recent Development
10.2 Owen Mumford
10.2.1 Owen Mumford Company Information
10.2.2 Owen Mumford Introduction and Business Overview
10.2.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Owen Mumford Wearable Injectors and Connected Devices Products Offered
10.2.5 Owen Mumford Recent Development
10.3 Sonceboz
10.3.1 Sonceboz Company Information
10.3.2 Sonceboz Introduction and Business Overview
10.3.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sonceboz Wearable Injectors and Connected Devices Products Offered
10.3.5 Sonceboz Recent Development
10.4 United Therapeutics
10.4.1 United Therapeutics Company Information
10.4.2 United Therapeutics Introduction and Business Overview
10.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 United Therapeutics Wearable Injectors and Connected Devices Products Offered
10.4.5 United Therapeutics Recent Development
10.5 Ypsomed
10.5.1 Ypsomed Company Information
10.5.2 Ypsomed Introduction and Business Overview
10.5.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ypsomed Wearable Injectors and Connected Devices Products Offered
10.5.5 Ypsomed Recent Development
10.6 Elcam Medical
10.6.1 Elcam Medical Company Information
10.6.2 Elcam Medical Introduction and Business Overview
10.6.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Elcam Medical Wearable Injectors and Connected Devices Products Offered
10.6.5 Elcam Medical Recent Development
10.7 Enable Injections
10.7.1 Enable Injections Company Information
10.7.2 Enable Injections Introduction and Business Overview
10.7.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Enable Injections Wearable Injectors and Connected Devices Products Offered
10.7.5 Enable Injections Recent Development
10.8 Unilife Corporation
10.8.1 Unilife Corporation Company Information
10.8.2 Unilife Corporation Introduction and Business Overview
10.8.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Unilife Corporation Wearable Injectors and Connected Devices Products Offered
10.8.5 Unilife Corporation Recent Development
10.9 West Pharma
10.9.1 West Pharma Company Information
10.9.2 West Pharma Introduction and Business Overview
10.9.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 West Pharma Wearable Injectors and Connected Devices Products Offered
10.9.5 West Pharma Recent Development
10.10 Eitan Medical
10.10.1 Eitan Medical Company Information
10.10.2 Eitan Medical Introduction and Business Overview
10.10.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Eitan Medical Wearable Injectors and Connected Devices Products Offered
10.10.5 Eitan Medical Recent Development
10.11 BD Medical
10.11.1 BD Medical Company Information
10.11.2 BD Medical Introduction and Business Overview
10.11.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 BD Medical Wearable Injectors and Connected Devices Products Offered
10.11.5 BD Medical Recent Development
10.12 Noble International
10.12.1 Noble International Company Information
10.12.2 Noble International Introduction and Business Overview
10.12.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Noble International Wearable Injectors and Connected Devices Products Offered
10.12.5 Noble International Recent Development
10.13 Insulet
10.13.1 Insulet Company Information
10.13.2 Insulet Introduction and Business Overview
10.13.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Insulet Wearable Injectors and Connected Devices Products Offered
10.13.5 Insulet Recent Development
10.14 Amgen
10.14.1 Amgen Company Information
10.14.2 Amgen Introduction and Business Overview
10.14.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Amgen Wearable Injectors and Connected Devices Products Offered
10.14.5 Amgen Recent Development
10.15 Roche
10.15.1 Roche Company Information
10.15.2 Roche Introduction and Business Overview
10.15.3 Roche Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Roche Wearable Injectors and Connected Devices Products Offered
10.15.5 Roche Recent Development
10.16 CeQur
10.16.1 CeQur Company Information
10.16.2 CeQur Introduction and Business Overview
10.16.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 CeQur Wearable Injectors and Connected Devices Products Offered
10.16.5 CeQur Recent Development
10.17 ScPharmaceuticals
10.17.1 ScPharmaceuticals Company Information
10.17.2 ScPharmaceuticals Introduction and Business Overview
10.17.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2018-2023)
10.17.4 ScPharmaceuticals Wearable Injectors and Connected Devices Products Offered
10.17.5 ScPharmaceuticals Recent Development11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Wearable Injectors and Connected Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Wearable Injectors and Connected Devices Industrial Chain Analysis
11.4 Wearable Injectors and Connected Devices Market Dynamics
11.4.1 Wearable Injectors and Connected Devices Industry Trends
11.4.2 Wearable Injectors and Connected Devices Market Drivers
11.4.3 Wearable Injectors and Connected Devices Market Challenges
11.4.4 Wearable Injectors and Connected Devices Market Restraints12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Wearable Injectors and Connected Devices Distributors
12.3 Wearable Injectors and Connected Devices Downstream Customers13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables Table 1. Major Company of Disposable Table 2. Major Company of Reusable Table 3. Global Wearable Injectors and Connected Devices Sales by Type 2018 VS 2022 VS 2029 (US$ Million) Table 4. Global Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (K Units) Table 5. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Type (2018-2023) Table 6. Global Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US& Million) Table 7. Global Wearable Injectors and Connected Devices Market Share in Value by Type (2018-2023) Table 8. Global Wearable Injectors and Connected Devices Price by Type (2018-2023) & (US$/Unit) Table 9. Global Wearable Injectors and Connected Devices Sales by Type (2024-2029) & (K Units) Table 10. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Type (2024-2029) Table 11. Global Wearable Injectors and Connected Devices Sales by Type (2024-2029) & (US$ Million) Table 12. Global Wearable Injectors and Connected Devices Sales Market Share in Value by Type (2024-2029) Table 13. Global Wearable Injectors and Connected Devices Price by Type (2024-2029) & (US$/Unit) Table 14. North America Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (K Units) Table 15. North America Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US$ Million) Table 16. Europe Wearable Injectors and Connected Devices Sales (K Units) by Type (2018-2023) Table 17. Europe Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US$ Million) Table 18. Asia-Pacific Wearable Injectors and Connected Devices Sales (K Units) by Type (2018-2023) Table 19. Asia-Pacific Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US$ Million) Table 20. Latin America Wearable Injectors and Connected Devices Sales (K Units) by Type (2018-2023) Table 21. Latin America Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US$ Million) Table 22. Middle East and Africa Wearable Injectors and Connected Devices Sales (K Units) by Type (2018-2023) Table 23. Middle East and Africa Wearable Injectors and Connected Devices Sales by Type (2018-2023) & (US$ Million) Table 24. Global Wearable Injectors and Connected Devices Sales by Company (2018-2023) & (K Units) Table 25. Global Wearable Injectors and Connected Devices Sales Share by Company (2018-2023) Table 26. Global Wearable Injectors and Connected Devices Revenue by Company (2018-2023) & (US$ Million) Table 27. Global Wearable Injectors and Connected Devices Revenue Share by Company (2018-2023) Table 28. Global Market Wearable Injectors and Connected Devices Price by Company (2018-2023) & (US$/Unit) Table 29. Global Wearable Injectors and Connected Devices Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Wearable Injectors and Connected Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wearable Injectors and Connected Devices as of 2022) Table 32. Date of Key Manufacturers Enter into Wearable Injectors and Connected Devices Market Table 33. Key Manufacturers Wearable Injectors and Connected Devices Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Wearable Injectors and Connected Devices Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029 Table 36. Global Wearable Injectors and Connected Devices Sales by Region (2018-2023) & (K Units) Table 37. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Region (2018-2023) Table 38. Global Wearable Injectors and Connected Devices Sales by Region (2018-2023) & (US$ Million) Table 39. Global Wearable Injectors and Connected Devices Sales Market Share in Value by Region (2018-2023) Table 40. Global Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 41. Global Wearable Injectors and Connected Devices Sales by Region (2024-2029) & (K Units) Table 42. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Region (2024-2029) Table 43. Global Wearable Injectors and Connected Devices Sales by Region (2024-2029) & (US$ Million) Table 44. Global Wearable Injectors and Connected Devices Sales Market Share in Value by Region (2024-2029) Table 45. Global Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029) Table 46. Global Wearable Injectors and Connected Devices Sales by Application: 2018 VS 2022 VS 2029 (US$ Million) Table 47. Global Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (K Units) Table 48. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Application (2018-2023) Table 49. Global Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 50. Global Wearable Injectors and Connected Devices Sales Market Share in Value by Application (2018-2023) Table 51. Global Wearable Injectors and Connected Devices Price by Application (2018-2023) & (US$/Unit) Table 52. Global Wearable Injectors and Connected Devices Sales by Application (2024-2029) & (K Units) Table 53. Global Wearable Injectors and Connected Devices Sales Market Share in Volume by Application (2024-2029) Table 54. Global Wearable Injectors and Connected Devices Sales by Application (2024-2029) & (US$ Million) Table 55. Global Wearable Injectors and Connected Devices Sales Market Share in Value by Application (2024-2029) Table 56. Global Wearable Injectors and Connected Devices Price by Application (2024-2029) & (US$/Unit) Table 57. North America Wearable Injectors and Connected Devices Sales by Application (2018-2023) (K Units) Table 58. North America Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 59. Europe Wearable Injectors and Connected Devices Sales by Application (2018-2023) (K Units) Table 60. Europe Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 61. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2018-2023) (K Units) Table 62. Asia-Pacific Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 63. Latin America Wearable Injectors and Connected Devices Sales by Application (2018-2023) (K Units) Table 64. Latin America Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 65. Middle East and Africa Wearable Injectors and Connected Devices Sales by Application (2018-2023) (K Units) Table 66. Middle East and Africa Wearable Injectors and Connected Devices Sales by Application (2018-2023) & (US$ Million) Table 67. North America Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (K Units) Table 68. North America Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2018-2023) Table 69. North America Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (US$ Million) Table 70. North America Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2018-2023) Table 71. North America Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (K Units) Table 72. North America Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2024-2029) Table 73. North America Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (US$ Million) Table 74. North America Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2024-2029) Table 75. Europe Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (K Units) Table 76. Europe Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2018-2023) Table 77. Europe Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (US$ Million) Table 78. Europe Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2018-2023) Table 79. Europe Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (K Units) Table 80. Europe Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2024-2029) Table 81. Europe Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (US$ Million) Table 82. Europe Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2024-2029) Table 83. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2018-2023) & (K Units) Table 84. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Volume by Region (2018-2023) Table 85. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2018-2023) & (US$ Million) Table 86. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Value by Region (2018-2023) Table 87. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2024-2029) & (K Units) Table 88. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Volume by Region (2024-2029) Table 89. Asia-Pacific Wearable Injectors and Connected Devices Sales by Region (2024-2029) & (US$ Million) Table 90. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Value by Region (2024-2029) Table 91. Latin America Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (K Units) Table 92. Latin America Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2018-2023) Table 93. Latin America Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (US$ Million) Table 94. Latin America Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2018-2023) Table 95. Latin America Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (K Units) Table 96. Latin America Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2024-2029) Table 97. Latin America Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (US$ Million) Table 98. Latin America Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2024-2029) Table 99. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (K Units) Table 100. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2018-2023) Table 101. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2018-2023) & (US$ Million) Table 102. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2018-2023) Table 103. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (K Units) Table 104. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Volume by Country (2024-2029) Table 105. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2024-2029) & (US$ Million) Table 106. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Value by Country (2024-2029) Table 107. Gerresheimer Company Information Table 108. Gerresheimer Introduction and Business Overview Table 109. Gerresheimer Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 110. Gerresheimer Wearable Injectors and Connected Devices Product Table 111. Gerresheimer Recent Development Table 112. Owen Mumford Company Information Table 113. Owen Mumford Introduction and Business Overview Table 114. Owen Mumford Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 115. Owen Mumford Wearable Injectors and Connected Devices Product Table 116. Owen Mumford Recent Development Table 117. Sonceboz Company Information Table 118. Sonceboz Introduction and Business Overview Table 119. Sonceboz Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 120. Sonceboz Wearable Injectors and Connected Devices Product Table 121. Sonceboz Recent Development Table 122. United Therapeutics Company Information Table 123. United Therapeutics Introduction and Business Overview Table 124. United Therapeutics Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 125. United Therapeutics Wearable Injectors and Connected Devices Product Table 126. United Therapeutics Recent Development Table 127. Ypsomed Company Information Table 128. Ypsomed Introduction and Business Overview Table 129. Ypsomed Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 130. Ypsomed Wearable Injectors and Connected Devices Product Table 131. Ypsomed Recent Development Table 132. Elcam Medical Company Information Table 133. Elcam Medical Introduction and Business Overview Table 134. Elcam Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 135. Elcam Medical Wearable Injectors and Connected Devices Product Table 136. Elcam Medical Recent Development Table 137. Enable Injections Company Information Table 138. Enable Injections Introduction and Business Overview Table 139. Enable Injections Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 140. Enable Injections Wearable Injectors and Connected Devices Product Table 141. Enable Injections Recent Development Table 142. Unilife Corporation Company Information Table 143. Unilife Corporation Introduction and Business Overview Table 144. Unilife Corporation Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 145. Unilife Corporation Wearable Injectors and Connected Devices Product Table 146. Unilife Corporation Recent Development Table 147. West Pharma Company Information Table 148. West Pharma Introduction and Business Overview Table 149. West Pharma Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 150. West Pharma Wearable Injectors and Connected Devices Product Table 151. West Pharma Recent Development Table 152. Eitan Medical Company Information Table 153. Eitan Medical Introduction and Business Overview Table 154. Eitan Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 155. Eitan Medical Wearable Injectors and Connected Devices Product Table 156. Eitan Medical Recent Development Table 157. BD Medical Company Information Table 158. BD Medical Introduction and Business Overview Table 159. BD Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 160. BD Medical Wearable Injectors and Connected Devices Product Table 161. BD Medical Recent Development Table 162. Noble International Company Information Table 163. Noble International Introduction and Business Overview Table 164. Noble International Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 165. Noble International Wearable Injectors and Connected Devices Product Table 166. Noble International Recent Development Table 167. Insulet Company Information Table 168. Insulet Introduction and Business Overview Table 169. Insulet Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 170. Insulet Wearable Injectors and Connected Devices Product Table 171. Insulet Recent Development Table 172. Amgen Company Information Table 173. Amgen Introduction and Business Overview Table 174. Amgen Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 175. Amgen Wearable Injectors and Connected Devices Product Table 176. Amgen Recent Development Table 177. Roche Company Information Table 178. Roche Introduction and Business Overview Table 179. Roche Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 180. Roche Wearable Injectors and Connected Devices Product Table 181. Roche Recent Development Table 182. CeQur Company Information Table 183. CeQur Introduction and Business Overview Table 184. CeQur Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 185. CeQur Wearable Injectors and Connected Devices Product Table 186. CeQur Recent Development Table 187. ScPharmaceuticals Company Information Table 188. ScPharmaceuticals Introduction and Business Overview Table 189. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 190. ScPharmaceuticals Wearable Injectors and Connected Devices Product Table 191. ScPharmaceuticals Recent Development Table 192. Key Raw Materials Lists Table 193. Raw Materials Key Suppliers Lists Table 194. Wearable Injectors and Connected Devices Market Trends Table 195. Wearable Injectors and Connected Devices Market Drivers Table 196. Wearable Injectors and Connected Devices Market Challenges Table 197. Wearable Injectors and Connected Devices Market Restraints Table 198. Wearable Injectors and Connected Devices Distributors List Table 199. Wearable Injectors and Connected Devices Downstream Customers Table 200. Research Programs/Design for This Report Table 201. Key Data Information from Secondary Sources Table 202. Key Data Information from Primary Sources List of Figures Figure 1. Wearable Injectors and Connected Devices Product Picture Figure 2. Global Wearable Injectors and Connected Devices Market Size, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global Wearable Injectors and Connected Devices Market Size Status and Outlook (2018-2029) & (US$ Million) Figure 4. Global Wearable Injectors and Connected Devices Sales Status and Outlook (2018-2029) & (K Units) Figure 5. Product Picture of Disposable Figure 6. Global Disposable Sales YoY Growth (2018-2029) & (K Units) Figure 7. Product Picture of Reusable Figure 8. Global Reusable Sales YoY Growth (2018-2029) & (K Units) Figure 9. Global Wearable Injectors and Connected Devices Sales by Type (2018-2029) & (US$ Million) Figure 10. Global Wearable Injectors and Connected Devices Sales Market Share by Type in 2022 & 2029 Figure 11. North America Wearable Injectors and Connected Devices Sales Market Share in Volume by Type in 2022 Figure 12. North America Wearable Injectors and Connected Devices Sales Market Share in Value by Type in 2022 Figure 13. Europe Wearable Injectors and Connected Devices Sales Market Share in Volume by Type in 2022 Figure 14. Europe Wearable Injectors and Connected Devices Sales Market Share in Value by Type in 2022 Figure 15. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Volume by Type in 2022 Figure 16. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Value by Type in 2022 Figure 17. Latin America Wearable Injectors and Connected Devices Sales Market Share in Volume by Type in 2022 Figure 18. Latin America Wearable Injectors and Connected Devices Sales Market Share in Value by Type in 2022 Figure 19. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Volume by Type in 2022 Figure 20. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Value by Type in 2022 Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Wearable Injectors and Connected Devices Sales in 2022 Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Wearable Injectors and Connected Devices Revenue in 2022 Figure 23. Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 24. Product Picture of Hospitals Figure 25. Global Hospitals Sales YoY Growth (2018-2029) & (K Units) Figure 26. Product Picture of Clinics Figure 27. Global Clinics Sales YoY Growth (2018-2029) & (K Units) Figure 28. Product Picture of Home Care Settings Figure 29. Global Home Care Settings Sales YoY Growth (2018-2029) & (K Units) Figure 30. Product Picture of Others Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 32. Global Wearable Injectors and Connected Devices Sales by Application (2018-2029) & (US$ Million) Figure 33. Global Wearable Injectors and Connected Devices Sales Market Share by Application in 2022 & 2029 Figure 34. North America Wearable Injectors and Connected Devices Sales Market Share in Volume by Application in 2022 Figure 35. North America Wearable Injectors and Connected Devices Sales Market Share in Value by Application in 2022 Figure 36. Europe Wearable Injectors and Connected Devices Sales Market Share in Volume by Application in 2022 Figure 37. Europe Wearable Injectors and Connected Devices Sales Market Share in Value by Application in 2022 Figure 38. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Volume by Application in 2022 Figure 39. Asia-Pacific Wearable Injectors and Connected Devices Sales Market Share in Value by Application in 2022 Figure 40. Latin America Wearable Injectors and Connected Devices Sales Market Share in Volume by Application in 2022 Figure 41. Latin America Wearable Injectors and Connected Devices Sales Market Share in Value by Application in 2022 Figure 42. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share in Value by Application in 2022 Figure 43. Key Raw Materials Price Figure 44. Wearable Injectors and Connected Devices Manufacturing Cost Structure Figure 45. Wearable Injectors and Connected Devices Industrial Chain Analysis Figure 46. Channels of Distribution Figure 47. Distributors Profiles Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed
Wearable Injectors and Connected Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Wearable Injectors and Connected Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Wearable Injectors and Connected Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Wearable Injectors and Connected Devices key manufacturers include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation and West Pharma, etc. Gerresheimer, Owen Mumford, Sonceboz are top 3 players and held % sales share in total in 2022. Wearable Injectors and Connected Devices can be divided into Disposable and Reusable, etc. Disposable is the mainstream product in the market, accounting for % sales share globally in 2022. Wearable Injectors and Connected Devices is widely used in various fields, such as Hospitals, Clinics, Home Care Settings and Others, etc. Hospitals provides greatest supports to the Wearable Injectors and Connected Devices industry development. In 2022, global % sales of Wearable Injectors and Connected Devices went into Hospitals filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Wearable Injectors and Connected Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Gerresheimer Owen Mumford Sonceboz United Therapeutics Ypsomed Elcam Medical Enable Injections Unilife Corporation West Pharma Eitan Medical BD Medical Noble International Insulet Amgen Roche CeQur ScPharmaceuticals Segment by Type Disposable Reusable Segment by Application Hospitals Clinics Home Care Settings Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the Wearable Injectors and Connected Devices market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Wearable Injectors and Connected Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Wearable Injectors and Connected Devices industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Wearable Injectors and Connected Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Wearable Injectors and Connected Devices introduction, etc. Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Wearable Injectors and Connected Devices market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now